Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4959)
All Articles published online
|
May 7, 2008 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hammerle CW, Surawicz CM. Updates on treatment of irritable bowel syndrome. World J Gastroenterol 2008; 14(17): 2639-2649 [PMID: 18461649 DOI: 10.3748/wjg.14.2639] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i17/2639.htm |
| Number | Citing Articles |
| 1 |
S.O. Asagba ., G.E. Eriyamremu .. Oral Cadmium Exposure and Levels of Superoxide Dismutase, Catalase, Lipid Peroxidation and ATPases in the Eye. Research Journal of Environmental Toxicology 2007; 1(4): 204 doi: 10.3923/rjet.2007.204.209
|
| 2 |
A. V. Pushkina, E. B. Avalueva, I. G. Bakulin, A. A. Topanova, K. A. Klikunova, I. V. Lapinskii, S. I. Sitkin. Risk factors for various clinical variants of irritable bowel syndrome. Experimental and Clinical Gastroenterology 2022; (5): 39 doi: 10.31146/1682-8658-ecg-201-5-39-48
|
| 3 |
S. Bourgoin, A. Gautier, M. Hamon. Le yin et le yang de la sérotonine : un Janus dans les contrôles de la douleur. Douleur et Analgésie 2017; 30(1): 35 doi: 10.1007/s11724-017-0486-3
|
| 4 |
Graeme Tobyn, Alison Denham, Margaret Whitelegg. Medical Herbs. 2011; : 241 doi: 10.1016/B978-0-443-10344-5.00029-X
|
| 5 |
P. M. HELLSTRÖM, J. HEIN, P. BYTZER, E. BJÖRNSSÖN, J. KRISTENSEN, H. SCHAMBYE. Clinical trial: the glucagon‐like peptide‐1 analogue ROSE‐010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo‐controlled, double‐blind study. Alimentary Pharmacology & Therapeutics 2009; 29(2): 198 doi: 10.1111/j.1365-2036.2008.03870.x
|
| 6 |
Reizdarmsyndrom wird immer besser verstanden. MMW - Fortschritte der Medizin 2014; 156(19): 60 doi: 10.1007/s15006-014-3643-0
|
| 7 |
Stanislas A. Doffou, Kissi Henriette Anzouan-Kacou, Eugene K. Messou, Demba A. Bangoura, Dimitri H. Kouamé, Kouame M. Alassan, Constant Assi, Fulgence Mamert Y. Bathaix, Alain K. Attia, Marie-Jeanne K. Lohoues. Assessment of the Efficacy of Rifaximin in the Management of Irritable Bowel Syndrome (IBS). Open Journal of Gastroenterology 2017; 7(10): 261 doi: 10.4236/ojgas.2017.710027
|
| 8 |
Parisa Heydari, Mustafa Ghanadian, Gholamreza Asghari, Maryam Azimi, Mahmoud Babaeian, Peyman Adibi. A double-blind randomized clinical trial of Dracocephalum kotschyi Boiss. in the patients with diarrhea-predominant irritable bowel syndrome. Research in Pharmaceutical Sciences 2023; 18(1): 89 doi: 10.4103/1735-5362.363599
|
| 9 |
Eduardo Esteban-Zubero, Laura López-Pingarrón, Moisés Alejandro Alatorre-Jiménez, Purificación Ochoa-Moneo, Celia Buisac-Ramón, Miguel Rivas-Jiménez, Silvia Castán-Ruiz, Ángel Antoñanzas-Lombarte, Dun-Xian Tan, José Joaquín García, Russel J. Reiter. Melatonin's role as a co-adjuvant treatment in colonic diseases: A review. Life Sciences 2017; 170: 72 doi: 10.1016/j.lfs.2016.11.031
|
| 10 |
Heraldo A.C. Rocha, Thiago V. Rocha, Fernando J.F. Nóbrega, Liana C.S. Morais, Margareth F.F.M. Diniz. Randomized controlled trial of Panax ginseng in patients with irritable bowel syndrome. Revista Brasileira de Farmacognosia 2018; 28(2): 218 doi: 10.1016/j.bjp.2018.02.007
|
| 11 |
B. Bonaz, J.-M. Sabate. Le dysfonctionnement du « brain-gut ». Gastroentérologie Clinique et Biologique 2009; 33: S48 doi: 10.1016/S0399-8320(09)71525-8
|
| 12 |
Yu Jin, Yan Lin, Lianjie Lin, Changqing Zheng. IL-17/IFN-γInteractions Regulate Intestinal Inflammation in TNBS-Induced Acute Colitis. Journal of Interferon & Cytokine Research 2012; 32(11): 548 doi: 10.1089/jir.2012.0030
|
| 13 |
Xiangping Wang, Yikuan Feng, Jiansheng Li, Zibin Tian, Dong Wei, Lingzhi Qi, Lifeng Fang, Kaichun Wu. Routine clinical administration of 4-week alverine citrate and simeticone combination relief global IBS symptoms. Open Journal of Gastroenterology 2014; 4(01): 32 doi: 10.4236/ojgas.2014.41006
|
| 14 |
Lokesh Agrawal, Mustafa Korkutata, Sunil Kumar Vimal, Manoj Kumar Yadav, Sanjib Bhattacharyya, Takashi Shiga. Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut. Neuropharmacology 2020; 166: 107969 doi: 10.1016/j.neuropharm.2020.107969
|
| 15 |
Orla F Craig, Eamonn MM Quigley. Bacteria, genetics and irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology 2010; 4(3): 271 doi: 10.1586/egh.10.31
|
| 16 |
He Zhu, Xi Xiao, Yuna Chai, Detang Li, Xue Yan, Hongmei Tang. MiRNA-29a modulates visceral hyperalgesia in irritable bowel syndrome by targeting HTR7. Biochemical and Biophysical Research Communications 2019; 511(3): 671 doi: 10.1016/j.bbrc.2019.02.126
|
| 17 |
H. Mönnikes, S. Müller-Lissner. Funktionelle Magen- und Darmerkrankungen. Der Gastroenterologe 2008; 3(5): 415 doi: 10.1007/s11377-008-0224-8
|
| 18 |
|
| 19 |
Robert V. Bryant, Daniel R. van Langenberg, Gerald J. Holtmann, Jane M. Andrews. Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology 2011; 26(5): 916 doi: 10.1111/j.1440-1746.2011.06624.x
|
| 20 |
Xudan Lei, Zhenni Xu, Lingxiao Huang, Yujun Huang, Siyu Tu, Lu Xu, Dengqun Liu. The potential influence of melatonin on mitochondrial quality control: a review. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1332567
|
| 21 |
Raish Oozeer, Patrick Veiga. Probiotic Foods in Health and Disease. 2011; : 75 doi: 10.1201/b10770-9
|
| 22 |
Jinjoo Kim, Kumsun Cho, Joo Sung Kim, Hyun Chae Jung, Bumsik Kim, Myeong Soo Park, Geun Eog Ji, Joo-Youn Cho, Kyoung Sup Hong. Probiotic treatment induced change of inflammation related metabolites in IBS-D patients/double-blind, randomized, placebo-controlled trial. Food Science and Biotechnology 2020; 29(6): 837 doi: 10.1007/s10068-019-00717-2
|
| 23 |
Bo Lian, Louis Vera-Portocarrero, Tamara King, Michael H. Ossipov, Frank Porreca. Opioid-induced latent sensitization in a model of non-inflammatory viscerosomatic hypersensitivity. Brain Research 2010; 1358: 64 doi: 10.1016/j.brainres.2010.08.032
|
| 24 |
Ning Ma, Jie Zhang, Russel J. Reiter, Xi Ma. Melatonin mediates mucosal immune cells, microbial metabolism, and rhythm crosstalk: A therapeutic target to reduce intestinal inflammation. Medicinal Research Reviews 2020; 40(2): 606 doi: 10.1002/med.21628
|
| 25 |
Sabine Krüger. Osteopathische Behandlung des Reizdarmsyndroms – ein Review. Osteopathische Medizin 2016; 17(4): 22 doi: 10.1016/S1615-9071(16)30083-1
|
| 26 |
Jagadeesh Menon, Babu Ram Thapa, Rajni Kumari, Srikanth Puttaiah Kadyada, Satyavati Rana, Sadhna B. Lal. Efficacy of Oral Psyllium in Pediatric Irritable Bowel Syndrome. Journal of Pediatric Gastroenterology and Nutrition 2023; 76(1): 14 doi: 10.1097/MPG.0000000000003622
|
| 27 |
Brooks D. Cash, Brian E. Lacy, Tharaknath Rao, David L. Earnest. Rifaximin and eluxadoline — newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?. Expert Opinion on Pharmacotherapy 2016; 17(3): 311 doi: 10.1517/14656566.2016.1118052
|
| 28 |
Israel Franco, Stephen Cagliostro, Therese Collett-Gardere, Mary Kearins, Paul Zelkovic, Lori Dyer, Edward F Reda. Treatment of Lower Urinary Tract Symptoms in Children With Constipation Using Tegaserod Therapy. UroToday International Journal 2010; 3(03) doi: 10.3834/uij.1944-5784.2010.06.17
|
| 29 |
Tina Didari, Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World Journal of Gastroenterology 2015; 21(10): 3072-3084 doi: 10.3748/wjg.v21.i10.3072
|
| 30 |
Aileen F. Har, Joseph M. B. Croffie. Pediatric Neurogastroenterology. 2017; : 469 doi: 10.1007/978-3-319-43268-7_44
|
| 31 |
Mark Pimentel, Anthony Lembo, William D. Chey, Salam Zakko, Yehuda Ringel, Jing Yu, Shadreck M. Mareya, Audrey L. Shaw, Enoch Bortey, William P. Forbes. Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation. New England Journal of Medicine 2011; 364(1): 22 doi: 10.1056/NEJMoa1004409
|
| 32 |
J. M. Remes‐Troche, M. Torres‐Aguilera, V. Montes‐Martínez, V. A. Jiménez‐García, F. Roesch‐Dietlen. Prevalence of irritable bowel syndrome in caregivers of patients with chronic diseases. Neurogastroenterology & Motility 2015; 27(6): 824 doi: 10.1111/nmo.12556
|
| 33 |
Pier Francesco Almerigi, Mauro Menarini, Gabriele Bazzocchi. Pelvic Floor Disorders. 2010; : 539 doi: 10.1007/978-88-470-1542-5_74
|
| 34 |
Lynne V McFarland. State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008. World Journal of Gastroenterology 2008; 14(17): 2625-2629 doi: 10.3748/wjg.14.2625
|
| 35 |
Julie E Stevens, Karen L Jones, Christopher K Rayner, Michael Horowitz. Pathophysiology and pharmacotherapy of gastroparesis: current and future perspectives. Expert Opinion on Pharmacotherapy 2013; 14(9): 1171 doi: 10.1517/14656566.2013.795948
|
| 36 |
Yi‐Ling Ye, Huei‐Shin Chang, Yu‐Fang Tseng, Li‐Shian Shi. Suppression of IL‐8 Release by Sweet Olive Ethanolic Extract and Compounds in WiDr Colon Adenocarcinoma Cells. Journal of Food Science 2017; 82(8): 1792 doi: 10.1111/1750-3841.13786
|
| 37 |
H. V. Lukyantseva, T. M. Oliinyk, P. V. Kirichek, N. V. Motorna, Yu. P. Luts. MODERN VIEW OF REGULATORY MECHANISMS OF MOTOR FUNCTION OF THE COLON . Bulletin of Problems Biology and Medicine 2021; 4(1): 40 doi: 10.29254/2077-4214-2021-4-162-40-46
|
| 38 |
Teita Asano, Ken-ichiro Tanaka, Arisa Tada, Hikaru Shimamura, Rikako Tanaka, Hiroki Maruoka, Mitsuko Takenaga, Tohru Mizushima. Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome. Scientific Reports 2017; 7(1) doi: 10.1038/srep40214
|
| 39 |
T. M. Oliinyk, K. V. Rozova, O. I. Kovalchuk, T. Ya. Raskaliei, V. B. Raskaliei, Yu. K. Khmelnytska. THE PARTICIPATION OF HUMORAL MECHANISMS IN THE REGULATION OF THE CONTRACTILE ACTIVITY OF SMOOTH MUSCLE TISSUE OF THE INTESTINE. Bulletin of Problems Biology and Medicine 2023; 1(2): 42 doi: 10.29254/2077-4214-2023-4-171-42-47
|
| 40 |
Aileen F. Har, Joseph M. B. Croffie. Pediatric Neurogastroenterology. 2013; : 441 doi: 10.1007/978-1-60761-709-9_41
|
| 41 |
Teita Asano, Ken-ichiro Tanaka, Shintaro Suemasu, Tomoaki Ishihara, Kayoko Tahara, Toshio Suzuki, Hidekazu Suzuki, Shin Fukudo, Tohru Mizushima. Effects of β-(1,3–1,6)-d-glucan on irritable bowel syndrome-related colonic hypersensitivity. Biochemical and Biophysical Research Communications 2012; 420(2): 444 doi: 10.1016/j.bbrc.2012.03.015
|
| 42 |
Kristin A. Zernicke, Tavis S. Campbell, Philip K. Blustein, Tak S. Fung, Jillian A. Johnson, Simon L. Bacon, Linda E. Carlson. Mindfulness-Based Stress Reduction for the Treatment of Irritable Bowel Syndrome Symptoms: A Randomized Wait-list Controlled Trial. International Journal of Behavioral Medicine 2013; 20(3): 385 doi: 10.1007/s12529-012-9241-6
|